A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 19997905)

Published in Osteoporos Int on December 09, 2009

Authors

J S B Carvas1, R M R Pereira, V F Caparbo, P Fuller, C A Silveira, L A P Lima, E Bonfa, S B V Mello

Author Affiliations

1: Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455, 3 masculine andar, Reumatologia, São Paulo, SP, 0124-6903, Brazil.

Articles cited by this

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27

Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med (1983) 3.17

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet (2009) 3.16

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94

A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res (2004) 2.92

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ (1996) 2.19

Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res (2008) 2.04

Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis (1995) 1.73

Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med (2000) 1.62

A longitudinal study of the growth of the New Zealand white rabbit: cumulative and biweekly incremental growth rates for body length, body weight, femoral length, and tibial length. J Orthop Res (1986) 1.32

Biology of implant osseointegration. J Musculoskelet Neuronal Interact (2009) 1.18

Mechanisms of failure of total hip replacements: lessons learned from retrieval studies. Clin Orthop Relat Res (2004) 1.18

Predictors of fractures in early rheumatoid arthritis. J Rheumatol (1991) 1.18

Characterization of a new experimental model of osteoporosis in rabbits. J Bone Miner Metab (2008) 1.11

Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat. J Bone Miner Res (2008) 1.11

Prolonged efficacy of a single dose of the bisphosphonate zoledronic acid. Clin Cancer Res (2007) 1.05

The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials (2009) 1.03

Strategies to affect bone remodeling: osteointegration. J Bone Miner Res (1993) 1.00

Implants in the medically compromised patient. Crit Rev Oral Biol Med (2003) 1.00

Why do dental implants fail? Part I. Implant Dent (1999) 0.98

Osseointegration of dental implants in rabbit bone with low mineral density. J Oral Maxillofac Surg (1997) 0.98

General and oral aspects of osteoporosis: a review. Clin Oral Investig (2001) 0.98

Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res (2003) 0.98

Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats. Bone (2008) 0.97

Zoledronic acid causes enhancement of bone growth into porous implants. J Bone Joint Surg Br (2005) 0.95

Bone reactions to titanium screw implants in ovariectomized animals. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.93

Local application of zoledronic acid incorporated in a poly(D,L-lactide)-coated implant accelerates fracture healing in rats. Acta Orthop (2008) 0.93

Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model. Acta Orthop Scand (2000) 0.93

Bone reactions around hydroxyapatite-coated implants in ovariectomized rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.91

The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro. J Biomed Mater Res A (2007) 0.90

Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite. J Bone Joint Surg Am (2008) 0.89

Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits. J Bone Miner Res (2002) 0.89

Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog. Calcif Tissue Int (2005) 0.88

Histomorphometric evaluation of titanium implants in osteoporotic rabbits. Implant Dent (2000) 0.87

Glucocorticoids in rheumatoid arthritis: effects on erosions and bone. Ann N Y Acad Sci (2002) 0.86

Cross-sectional analysis of the implant-abutment interface. J Oral Rehabil (2007) 0.85

Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone. Calcif Tissue Int (1997) 0.85

Radiographic assessment of bone density around integrated titanium implants after ovariectomy in rats. Clin Oral Implants Res (2006) 0.84

Bisphosphonates incorporated in a poly(D,L-lactide) implant coating inhibit osteoclast like cells in vitro. J Biomed Mater Res A (2007) 0.83

Early bone response to sandblasted, dual acid-etched and H2O2/HCl treated titanium implants: an experimental study in the rabbit. Int J Oral Maxillofac Surg (2009) 0.83

Effects of glucocorticoids on inflammation and arthritis. Curr Opin Rheumatol (2007) 0.83

Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry. Mod Rheumatol (2008) 0.83

The effect of high glucocorticoid administration and food restriction on rodent skeletal muscle mitochondrial function and protein metabolism. PLoS One (2009) 0.82

An update on glucocorticoid-induced osteoporosis. Curr Opin Rheumatol (2007) 0.82

The effect of an immunosuppressive therapy and its withdrawal on bone healing around titanium implants. A histometric study in rabbits. J Periodontol (2001) 0.78

Bone metabolic effects of single-dose zoledronate in healthy dogs. J Vet Intern Med (2005) 0.78

Osteoporosis-like bone conditions affect osseointegration of implants. Int J Oral Maxillofac Implants (2004) 0.78

Glucocorticoid eye drops inhibit growth in the newborn rabbit. Acta Paediatr (2005) 0.76

Nicotine and bone density around titanium implants: a histometric study in rabbits. Implant Dent (2002) 0.75

Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis. J Endocrinol Invest (2008) 0.75

Articles by these authors

Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med (1987) 2.47

Comparative study of axial and femoral bone mineral density and parameters of mandibular bone quality in patients receiving dental implants. Osteoporos Int (2006) 2.01

Clinical and serologic associations of the antiribosomal P protein antibody. Arthritis Rheum (1986) 1.58

Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia. Clin Exp Rheumatol (2011) 1.41

Lessons from a review of thyroglobulin assays in the management of thyroid cancer. Intern Med J (2008) 1.40

Balance training program is highly effective in improving functional status and reducing the risk of falls in elderly women with osteoporosis: a randomized controlled trial. Osteoporos Int (2006) 1.23

Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci U S A (1988) 1.22

Lipoprotein(a) levels in systemic lupus erythematosus. J Rheumatol (1994) 1.11

RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res (2005) 1.05

Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice. J Immunol (1989) 1.04

Persistent nocturnal cough: randomised controlled trial of high dose inhaled corticosteroid. Arch Dis Child (1999) 1.02

Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus. Lupus (2012) 1.01

Hirschsprung disease in an infant with a contiguous gene syndrome of chromosome 13. Am J Med Genet (2001) 1.00

Peripheral neuropathy in patients with primary antiphospholipid (Hughes') syndrome. Lupus (2010) 0.98

Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus. Arthritis Rheum (1988) 0.98

Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest (1994) 0.97

Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol (2006) 0.95

Lupus anti-ribosomal P peptide antibodies show limited heterogeneity and are predominantly of the IgG1 and IgG2 subclasses. Clin Immunol Immunopathol (1987) 0.94

A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases. Clin Exp Rheumatol (2010) 0.93

Antiribosomal antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am (1992) 0.91

Inflammatory cervicovaginal cytology is associated with disease activity in juvenile systemic lupus erythematosus. Lupus (2007) 0.91

Discriminating sarcopenia in community-dwelling older women with high frequency of overweight/obesity: the São Paulo Ageing & Health Study (SPAH). Osteoporos Int (2012) 0.90

Primary antiphospholipid syndrome in premenopausal women: low vitamin D, high fat mass and maintained bone mineral mass. Lupus (2010) 0.89

The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala. Brain Res (1999) 0.88

Prevalence of sarcopenia and associated risk factors by two diagnostic criteria in community-dwelling older men: the São Paulo Ageing & Health Study (SPAH). Osteoporos Int (2013) 0.88

Chronic blockade of nitric oxide biosynthesis in rats: effect on leukocyte endothelial interaction and on leukocyte recruitment. Inflamm Res (2004) 0.88

Bone metabolism and vascular calcification. Braz J Med Biol Res (2007) 0.88

Positive effects of football on fitness, lipid profile, and insulin resistance in Brazilian patients with type 2 diabetes. Scand J Med Sci Sports (2014) 0.88

PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. Lupus (2011) 0.87

Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy. Clin Exp Rheumatol (2012) 0.87

Comparative study of axial and femoral bone mineral density and parameters of mandibular bone quality in patients receiving dental implants. Osteoporos Int (2007) 0.86

Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus. Lupus (2007) 0.86

Antibodies against Rickettsiaceae in dogs of Setúbal, Portugal. Cent Eur J Public Health (1995) 0.85

The bipartite tarsal navicular bone: radiographic and computed tomography findings. Australas Radiol (1995) 0.85

Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria? Lupus (2013) 0.85

Prevalence and risk factors of radiographic vertebral fracture in Brazilian community-dwelling elderly. Osteoporos Int (2010) 0.85

Testicular Sertoli cell function in male systemic lupus erythematosus. Rheumatology (Oxford) (2008) 0.84

Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus (2012) 0.84

RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus. Osteoporos Int (2015) 0.83

Incidence and risk factors for osteoporotic vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The São Paulo Ageing & Health (SPAH) Study. Osteoporos Int (2014) 0.82

Menstrual and hormonal alterations in juvenile dermatomyositis. Clin Exp Rheumatol (2010) 0.82

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal. Lupus (2009) 0.82

Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol (1999) 0.82

Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker? Scand J Rheumatol (2008) 0.82

Minor sperm abnormalities in young male post-pubertal patients with juvenile dermatomyositis. Braz J Med Biol Res (2008) 0.82

Juvenile-onset Takayasu arteritis: peculiar vascular involvement and more refractory disease. Scand J Rheumatol (2010) 0.81

Overexpression of insulin-like growth factor binding protein-5 decreases osteoblastic function in vitro. Bone (2004) 0.81

Ribosomal protein autoantibodies in systemic lupus erythematosus. Bioessays (1987) 0.81

Development of morphological changes and ileal glucagon gene expression in the small intestine of lambs infected with Trichostrongylus colubriformis. J Comp Pathol (1996) 0.81

Increased arterial stiffness assessed by pulse wave velocity in Behçet's disease and its association with the lipid profile. J Eur Acad Dermatol Venereol (2012) 0.81

Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use. Scand J Rheumatol (2008) 0.80

Hemisphere functioning and motor imitation in autistic persons. Brain Cogn (1983) 0.80

C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats. Clin Exp Immunol (2002) 0.80

Vaccination, atherosclerosis and systemic lupus erythematosus. Lupus (2009) 0.79

Cerebral lateralization in individuals diagnosed as autistic in early childhood. Brain Lang (1982) 0.79

Premature coronary artery calcification is associated with disease duration and bone mineral density in young female systemic lupus erythematosus patients. Lupus (2009) 0.79

Interleukin-18 in chronic joint diseases. Autoimmun Rev (2006) 0.79

[Effectiveness of aminosidine sulphate in severe visceral leishmaniasis, resistant to the treatment with pentavalent antimony]. Rev Soc Bras Med Trop (1995) 0.78

Antiribosomal antibodies in SLE, infection, and following deliberate immunization. Adv Exp Med Biol (1994) 0.78

Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. Rheumatology (Oxford) (2005) 0.78

Immunohistochemical localization of La nuclear antigen in brain. Selective concentration of the La protein in neuronal nucleoli. J Neuroimmunol (1985) 0.77

Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol (2014) 0.77

Lupus pleuritis: a relevant risk factor for pulmonary tuberculosis. Lupus (2010) 0.77

Erratic control of breathing during exercise in patients with systemic lupus erythematosus: a pilot-study. Lupus (2011) 0.77

Impaired aerobic exercise capacity and cardiac autonomic control in primary antiphospholipid syndrome. Lupus (2013) 0.77

Decreased in vitro osteoblast proliferation and low turnover bone disease in nonuremic proteinuric patients. Kidney Int (2007) 0.76

Influence of ovariectomy and masticatory hypofunction on mandibular bone remodeling. Oral Dis (2009) 0.76

Left hemisphere specialization for facial and manual imitation. Psychophysiology (1985) 0.76

Chronic active hepatitis associated with anti-liver-kidney microsome antibody type 1. Arq Gastroenterol (1989) 0.75

The cellular and molecular basis of glucocorticoid actions in bone. Front Horm Res (2002) 0.75

Microcomputers at Ormerod School. Spec Educ Forward Trends (1983) 0.75

Uranium deposition in bones of Wistar rats associated with skeleton development. Appl Radiat Isot (2013) 0.75

Inactivation of alpha-amylase in wheat and flour with acid. J Sci Food Agric (1970) 0.75

Effect of topical clay application on the synthesis of collagen in skin: an experimental study. Clin Exp Dermatol (2012) 0.75

Eadweard James Muybridge 1830-1904. J Audiov Media Med (1998) 0.75

Hepatocyte growth factor gene expression after massive small bowel resection: lack of stimulation in lung and liver. Exp Clin Endocrinol Diabetes (1995) 0.75

Exercise training, creatine supplementation, and bone health in ovariectomized rats. Osteoporos Int (2015) 0.75

Persistent hypovitaminosis D and loss of hip bone mineral density over time as additional risk factors for recurrent falls in a population-based prospective cohort of elderly persons living in the community. The São Paulo Ageing & Health (SPAH) Study. Osteoporos Int (2015) 0.75

Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients. Osteoporos Int (2014) 0.75

Motor and cognitive interactions during lateralized cerebral functions in children: an EEG study. Cortex (1981) 0.75

Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients. Lupus (2013) 0.75

Late language development in a child unable to recognize or produce speech sounds. Arch Neurol (1983) 0.75

A re-evaluation of the tissue-specific pattern of expression of the rat kallikrein gene family. Agents Actions Suppl (1992) 0.75